Overall, these findings are consistent with decreased activation of the IL-6 trans-signaling pathway via a reduction in plasma and cortical IL-6, which we have previously hypothesized contributes to neuronal injury/neurodegeneration and ultimately delirium-like behaviors. The gene discussed is IL6; the disease is delirium.